These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 4909553

  • 21. [Comparative studies of the demonstration of antinuclear factors by immunofluorescence and antiglobulin consumption tests].
    Schmidt K, Mueller-Eckhardt C, Becker W.
    Verh Dtsch Ges Rheumatol; 1969; 1():251-8. PubMed ID: 4934585
    [No Abstract] [Full Text] [Related]

  • 22. Antigenicity of the nuclei of human leucocytes.
    Zitnan D, Cebecauer L.
    Folia Biol (Praha); 1968; 14(3):215-21. PubMed ID: 4873467
    [No Abstract] [Full Text] [Related]

  • 23. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
    Burnham TK, Neblett TR, Fine G.
    Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
    [No Abstract] [Full Text] [Related]

  • 24. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients.
    Mond CB, Peterson MG, Rothfield NF.
    Arthritis Rheum; 1989 Feb; 32(2):202-4. PubMed ID: 2493253
    [Abstract] [Full Text] [Related]

  • 25. Systemic lupus erythematosus. Laboratory studies.
    Rothfield NF.
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):299-303. PubMed ID: 400830
    [No Abstract] [Full Text] [Related]

  • 26. [Lichen ruber planus--lupus erythematosus/overlap syndrome].
    Stary A, Schwarz T, Duschet P, Gschnait F.
    Z Hautkr; 1987 Mar 01; 62(5):381-94. PubMed ID: 3296507
    [Abstract] [Full Text] [Related]

  • 27. [Studies on autoantibodies in systemic lupus erythematosus with peroxidase-labeled antibody technic. Ultrastructural localization of the antigens and a test for antinuclear and anticytoplasmic factors].
    Machida M.
    Nihon Naika Gakkai Zasshi; 1971 May 10; 60(5):408-19. PubMed ID: 4939865
    [No Abstract] [Full Text] [Related]

  • 28. [Negative antinuclear antibodies in disseminated lupus erythematosus. Report of 3 cases].
    González Ortega MA, Santos G, Reyes PA.
    Arch Inst Cardiol Mex; 1979 May 10; 49(6):1122-9. PubMed ID: 398681
    [Abstract] [Full Text] [Related]

  • 29. Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study.
    Tzaneva S, Volc-Platzer B, Kittler H, Hönigsmann H, Tanew A.
    Br J Dermatol; 2008 May 10; 158(5):1050-4. PubMed ID: 18341657
    [Abstract] [Full Text] [Related]

  • 30. [Demonstration of antinuclear antibodies in the epidermis of patients with progressive systemic sclerosis, generalized lupus erythematosus and dermatomyositis].
    Lamas Robles C, Mejía Arreguín S, Orozco Medina JH, González Mendoza A.
    Rev Invest Clin; 1984 May 10; 36(2):115-9. PubMed ID: 6385174
    [No Abstract] [Full Text] [Related]

  • 31. D.N.A. antibodies in systemic lupus erythematosus - an evaluation and a comparison of two techniques.
    Browne O, Holland PD, Maguire P.
    Ir Med J; 1981 Jul 10; 74(7):188-9. PubMed ID: 7021465
    [No Abstract] [Full Text] [Related]

  • 32. [Immunological studies on DNA antibodies in lupus erythematosus (SLE, cDLE), with particular reference to photo-oxidized DNA (poDNA) antibody].
    Okuda M.
    Arerugi; 1970 Apr 10; 19(4):260-6. PubMed ID: 5448917
    [No Abstract] [Full Text] [Related]

  • 33. Antinuclear factors. Their determination by immunofluorescence.
    Gheorghiu M, Purice S.
    Rom Med Rev; 1970 Apr 10; 14(4):32-5. PubMed ID: 4928683
    [No Abstract] [Full Text] [Related]

  • 34. [Focal epidermal necrolisis. A variation of lupus erythematosus of a new disease?].
    Piñól Aguadé J, Palou J, Lecha M, Castel T.
    Med Cutan Ibero Lat Am; 1977 Apr 10; 5(1):1-11. PubMed ID: 330980
    [Abstract] [Full Text] [Related]

  • 35. [Diagnosis of lupus erythematosus].
    Gschnait F, Brenner W, Holubar K.
    Hautarzt; 1979 Dec 10; 30(12):646-50. PubMed ID: 317653
    [Abstract] [Full Text] [Related]

  • 36. [Current significance of the LE-phenomenon and antinuclear seroreactions in clinical diagnosis].
    Beickert A.
    Z Arztl Fortbild (Jena); 1973 Jan 15; 67(2):75-9. PubMed ID: 4121746
    [No Abstract] [Full Text] [Related]

  • 37. [Clinical significance of antinuclear antibodies in systemic lupus erythematosus].
    Stefanović Z, Mijailović B.
    Vojnosanit Pregl; 1986 Jan 15; 43(1):16-21. PubMed ID: 3515753
    [No Abstract] [Full Text] [Related]

  • 38. [Determination of antinuclear antibody using LE fluorescent slide kit (KW) (authors transl)].
    Isobe J, Yoshioka H, Shinoara K, Shono K.
    Rinsho Byori; 1975 Jun 15; 23(6):457-60. PubMed ID: 1100884
    [No Abstract] [Full Text] [Related]

  • 39. Weighted criteria for the diagnosis of systemic lupus erythematosus.
    Clough JD, Elrazak M, Calabrese LH, Valenzuela R, Braun WB, Williams GW.
    Arch Intern Med; 1984 Feb 15; 144(2):281-5. PubMed ID: 6421256
    [Abstract] [Full Text] [Related]

  • 40. Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease.
    Provost TT, Watson R, Simmons-O'Brien E.
    J Am Acad Dermatol; 1996 Aug 15; 35(2 Pt 1):147-69; quiz 170-2. PubMed ID: 8708014
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.